Prudential Financial’s Achillion Pharmaceuticals ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-11,112
| Closed | -$67K | – | 2501 |
|
|
2019
Q4 | $67K | Sell |
11,112
-4,546
| -29% | -$26.3K | ﹤0.01% | 2388 |
|
|
2019
Q3 | $56K | Sell |
15,658
-2,077
| -12% | -$8.01K | ﹤0.01% | 2381 |
|
|
2019
Q2 | $48K | Hold |
17,735
| – | – | ﹤0.01% | 2425 |
|
|
2019
Q1 | $52K | Buy |
17,735
+5,623
| +46% | +$13.8K | ﹤0.01% | 2400 |
|
|
2018
Q4 | $19K | Sell |
12,112
-320
| -3% | -$905 | ﹤0.01% | 2363 |
|
|
2018
Q3 | $46K | Buy |
12,432
+410
| +3% | +$1.22K | ﹤0.01% | 2400 |
|
|
2018
Q2 | $34K | Sell |
12,022
-820
| -6% | -$2.79K | ﹤0.01% | 2414 |
|
|
2018
Q1 | $48K | Buy |
12,842
+1,700
| +15% | +$5.56K | ﹤0.01% | 2322 |
|
|
2017
Q4 | $32K | Sell |
11,142
-860
| -7% | -$3.12K | ﹤0.01% | 2318 |
|
|
2017
Q3 | $54K | Buy |
12,002
+370
| +3% | +$1.64K | ﹤0.01% | 2314 |
|
|
2017
Q2 | $53K | Hold |
11,632
| – | – | ﹤0.01% | 2319 |
|
|
2017
Q1 | $49K | Hold |
11,632
| – | – | ﹤0.01% | 2309 |
|
|
2016
Q4 | $48K | Hold |
11,632
| – | – | ﹤0.01% | 2316 |
|
|
2016
Q3 | $94K | Buy |
11,632
+790
| +7% | +$6.72K | ﹤0.01% | 2278 |
|
|
2016
Q2 | $85K | Buy |
+10,842
| New | +$93K | ﹤0.01% | 2261 |
|
|
2014
Q3 | – | Sell |
-16,251
| Closed | -$123K | – | 2356 |
|
|
2014
Q2 | $123K | Buy |
+16,251
| New | +$64.8K | ﹤0.01% | 2326 |
|
Prudential Financial's ACHN Position: Q1 2020 in Review
Prudential Financial sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 11,112 shares — an estimated $67K sold.
Prudential Financial first reported a position in ACHN in Q2 2014 and held it in 16 quarters. The position peaked at $123K in Q2 2014. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.
- Prudential Financial reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
- Prudential Financial sold 11,112 Achillion Pharmaceuticals shares in Q1 2020, an estimated $67K.
- Prudential Financial first reported a position in Achillion Pharmaceuticals in Q2 2014 and held it in 16 quarters.
- Prudential Financial's Achillion Pharmaceuticals position peaked at $123K in Q2 2014.
- 0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.
Based on Prudential Financial's 13F filing for Q1 2020, filed 12 May 2020.